» Articles » PMID: 12144598

Morbidity Associated with Non-fatal Heroin Overdose

Overview
Journal Addiction
Specialty Psychiatry
Date 2002 Jul 30
PMID 12144598
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To estimate the range and severity of heroin overdose related morbidity.

Design: Cross-sectional survey.

Setting: Sydney, Australia.

Participants: 198 heroin users.

Findings: Sixty-nine per cent had experienced a heroin overdose, 28% in the preceding 12 months. Of those who had overdosed, 79% had experienced at least one overdose-related morbidity symptom. An ambulance had attended overdoses for 59% of subjects, 33% had required hospital treatment for overdose, and 14% had experienced overdose-related complications of sufficient severity to be admitted to a hospital ward. Indirect overdose-related morbidity included: physical injury sustained when falling at overdose (40%), burns (24%) and assault while unconscious (14%). Direct overdose-related morbidity included: peripheral neuropathy (49%), vomiting (33%), temporary paralysis of limbs (26%), chest infections (13%) and seizure (2%).

Conclusions: There appears to be extensive morbidity associated with non-fatal overdose. This is clearly an area that requires more research to document the prevalence and nature of these harms, and factors associated with them.

Citing Articles

Take-home naloxone in multicentre emergency settings: the TIME feasibility cluster RCT.

Snooks H, Benger J, Bell F, Black S, Dixon S, Emery H Health Technol Assess. 2024; 28(74):1-69.

PMID: 39487686 PMC: 11586806. DOI: 10.3310/YNRC8249.


Collateral Damage: Neurological Correlates of Non-Fatal Overdose in the Era of Fentanyl-Xylazine.

Todaro D, Volkow N, Langleben D, Shi Z, Wiers C Neurosci Insights. 2024; 19:26331055241247156.

PMID: 39296815 PMC: 11409300. DOI: 10.1177/26331055241247156.


Cognitive Dysfunction in the Addictions (CDiA): A Neuron to Neighbourhood Collaborative Research Program on Executive Dysfunction and Functional Outcomes in Outpatients Seeking Treatment for Addiction.

Nikolova Y, Ruocco A, Felsky D, Lange S, Prevot T, Vieira E medRxiv. 2024; .

PMID: 39252904 PMC: 11383479. DOI: 10.1101/2024.08.30.24312806.


Barriers and Facilitators to Accessing Opioid Agonist Therapy for Street-involved Adolescents and Young Adults in Vancouver.

Gallant K, Nijjar P, DeBeck K, Cui M, Kerr T J Addict Med. 2024; 19(1):105-108.

PMID: 39207346 PMC: 11790360. DOI: 10.1097/ADM.0000000000001361.


Take-home naloxone administered in emergency settings: feasibility of intervention implementation in a cluster randomized trial.

Snooks H, Jones J, Bell F, Benger J, Black S, Dixon S BMC Emerg Med. 2024; 24(1):155.

PMID: 39198758 PMC: 11360782. DOI: 10.1186/s12873-024-01061-3.